In a letter to the editor published yesterday, AHA President and CEO Rick Pollack notes, “Even before the Covid-19 pandemic, the financial state of many hospitals was very fragile, with one of every four hospitals in America operating in the red.

“Every hospital in America prepared for Covid-19 patients. Moreover, every hospital stopped doing regularly scheduled procedures. As a result, expenses have skyrocketed and revenues have virtually dried up. Our own report found that hospitals and health systems are projected to lose more than $200 billion between March 1 and June 30 because of this pandemic.

“And while $44 billion in relief funds has been sent to hospitals, the government assistance won’t make up for the catastrophic financial losses created by Covid-19. Moody’s also found that the federal aid won’t completely cover the revenue hospitals will lose.

“We need support and resources to ensure that we can continue to deliver the critical care that our patients and communities depend on, while also ensuring that we are prepared for the continuing challenges we face from this pandemic, as well as other potential emergencies.”

Related News Articles

Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
The Home Test to Treat program now offers free testing, telehealth and treatment for both COVID-19 and flu to eligible adults nationwide, the National…
Headline
The Food and Drug Administration Nov. 9 cleared for marketing the Flowflex COVID-19 Antigen Home Test, the first COVID-19 antigen test and second COVID-19 at-…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…